Cosette Pharmaceuticals Inc., a Bridgewater-based generic pharmaceutical company focused on extending topical and suppository products, announced Monday it has acquired G&W Laboratories‘ finished dosage manufacturing plant in Lincolnton, North Carolina.
“The purchase of the Lincolnton plant expands Cosette’s capabilities into new dosage forms while simultaneously allowing us to enter a new business vertical that complements our overall growth strategy,” Walt Kaczmarek, CEO and president of Cosette, said.
“The Lincolnton facility has an excellent track record of producing liquid pharmaceuticals along with other differentiated dosage forms, and operates as a contract manufacturer across multiple presentations for select business partners. We look forward to integrating their expertise and capabilities to the Cosette family and adding value to the Cosette growth pathway,” he said.
Financial and other terms were not disclosed.